Dr. Hechtman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10065Phone+1 786-525-5689- Is this information wrong?
Summary
- I am a board certified anatomic pathologist with fellowship training in gastrointestinal pathology and molecular genetic pathology (also board certified). I practice both specialties as well as frozen sections. I currently have 6 years of experience as an attending. I also do independent and collaborative research, with over 50 publications in high impact journals.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Molecular Genetic Pathology, 2013 - 2014
- Icahn School of Medicine at Mount SinaiFellowship, Gastrointestinal Pathology, 2012 - 2013
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Pathology-Anatomic and Clinical, 2009 - 2012
- University of Miami Leonard M. Miller School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2024 - 2026
- NY State Medical License 2011 - 2025
- AZ State Medical License 2023 - 2025
- SC State Medical License 2023 - 2025
- MO State Medical License 2023 - 2025
- FL State Medical License 2020 - 2025
- OR State Medical License 2023 - 2025
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMicrosatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and...Soo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, Jason Chang, John Ziegler, Douglas A Mata, Liliana B Villafania, Khedoudja Nafa, Jaclyn F Hechtman, Ryma Benayed, Ahmet...> ;Journal of Thoracic Oncology. 2024 Mar 1
- Her2 low (but not negative): the newest biomarker on the block for gastro-oesophageal adenocarcinoma.Jaclyn Frances Hechtman> ;Journal of Clinical Pathology. 2023 Dec 1
- Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.Steven B Maron, Walid Chatila, Henry Walch, Joanne F Chou, Nicholas Ceglia, Ryan Ptashkin, Richard Kinh Gian Do, Viktoriya Paroder, Neeta Pandit-Taskar, Jason S Lewis,...> ;Clinical Cancer Research. 2023 Sep 15
- Join now to see all
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
- Baptist Hospital of MiamiMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: